Usage
  • 190 views
  • 233 downloads

Cellular immune responses to human betaretrovirus in patients with primary biliary cholangitis

  • Author / Creator
    Abofayed, Hiatem Abdullah
  • Human betaretrovirus (HBRV) infection has been characterized in patients with primary
    biliary cholangitis (PBC). Our lab has documented HBRV proviral integrations in bile ducts of PBC
    patients. However, serological diagnostics cannot detect HBRV infection in the majority of PBC
    patients, limiting further confirmation of viral infection. In FACS studies using pooled 17-20 aa
    peptides derived from the HBRV Gag (n=58) and Env (n=85) proteins, 40% of PBC patients
    PBMCs were found to make proinflammatory cellular immune responses to HBRV. Then, to
    characterize immunodominant HBRV epitopes, we screened intra-hepatic lymphocytes (IHL) from
    PBC patients and control subjects for evidence of IFN-γ production. IHL isolated from liver
    transplant recipients with PBC (n=8) and other hepatic disorders (n=9) were individually stimulated
    with 18-mer peptides from HBRV Gag or Env proteins (n=143) or the characterized CD8+ reactive
    epitope derived from the mitochondrial autoantigen, pyruvate dehydrogenase-E2 (PDC-E2).
    ELISpot was used to measure spot forming colonies (SFC) producing IFN-γ. 10 HBRV Gag and 12
    HBRV Env peptides were found to stimulate IHL. The mean number of SFC producing IFN-γ was
    higher in PBC patients versus control subjects. Using background cut off level of 1:100 SFC, the
    individual HBRV Gag and Env peptides provided a high specificity and sensitivity for detecting
    HBRV infection in PBC patients’ IHL. Notably, only one PBC patient had detectable IFN-γ
    producing IHL following stimulation with the characterized PDC-E2 peptide. These are the first
    data to demonstrate that the intrahepatic IFN-γ cellular immune responses to HBRV greatly exceed
    the autoimmune response, suggesting that HBRV infection plays an important role in mediating
    PBC. The identified HBRV peptides can be evaluated to measure the IFN-γ release in peripheral
    blood mononuclear cells and construct a diagnostic IFN-γ release assay

  • Subjects / Keywords
  • Graduation date
    Fall 2019
  • Type of Item
    Thesis
  • Degree
    Master of Science
  • DOI
    https://doi.org/10.7939/r3-vx0s-t176
  • License
    Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission.